Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,062.00
Bid: 12,018.00
Ask: 12,022.00
Change: 38.00 (0.32%)
Spread: 4.00 (0.033%)
Open: 11,950.00
High: 12,142.00
Low: 11,944.00
Prev. Close: 12,024.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Earnings momentum for the S&P

Fri, 12th Mar 2021 10:22

March 12 - Welcome to the home for real-time coverage of
markets brought to you by Reuters reporters. You can share your
thoughts with us at markets.research@thomsonreuters.com

EARNINGS MOMENTUM FOR THE S&P (1015 GMT)

The U.S. are expected to offset the adverse impact of rising
yields with a strong recovery coupled with expansion of
earnings, which is the main equity key driver.

“Much better than expected earnings should drive further S&P
500 upside through 2021,” UBS analysts say.

"We raise our S&P 500 price target for year end to 4250,
from 4100, on higher forecasted EPS of $188 for 2021 and $218
for 2022", they add.

While the Fed's policy will be crucial as higher rates have
an impact on stock valuations, politics also have to be closely
monitored. More corporate and capital gains taxes coupled with
greater regulation would reduce UBS estimates by 12%.

(Stefano Rebaudo)

*****

EUROPE ON THE BACKFOOT (0837 GMT)

A cocktail of reasons for the pullback in Europe this
morning, despite strong sessions in U.S. and Asia overnight. The
Stoxx 600 index is however comfortably poised to record a gain
for the week.

Concerns about the vaccination campaign, with AstraZeneca
further cutting its supply forecast are dampening risk
sentiment.

Then we have yields on the rise above 1.6% in early London
trading and China warning the United States to stop interfering
in its affairs, including Hong Kong.

The Stoxx 600 index is down 0.3%, with Tech stocks leading
losses down 1.2%, inline with Nasdaq futures.

Shares in online investor Prosus are down 4.4%,
after China's watchdog imposed administrative penalties on 12
companies including Internet giants Tencent and Baidu for
violating anti-monopoly law in 10 deals.

Bank stocks are in positive territory after
yesterday’s strong post-ECB selloff.

Burberry is the best performer of Stoxx 600, up 7%,
after the company raised its outlook.

(Stefano Rebaudo)

*****

TROUBLE RETURNS (0811 GMT)

U.S. 10-year Treasury yields are on track to rise for the
seventh week straight. But a measure of calm that had returned
in recent days seems to have dissipated on Friday as yields are
making their way back towards recent one-year highs above 1.6%.

Euro zone yields too are higher this morning, though to a
lesser extent, still benefiting from the ECB's promise to
accelerate emergency money-printing.

That in turn is putting the dampener on stock markets --
world stocks rose three days in a row as U.S. yields pulled back
but are now turning tail -- Nasdaq futures are down 1%. Futures
for the S&P500 and for European stocks are also weaker, albeit
to a lesser degree.

So what's going on? Jobs data on Thursday indicated the U.S.
economy is well on the road to recovery while President Joe
Biden signed into law a $1.9 trillion COVID-19 relief bill and
a 30-year Treasury auction had a mixed outcome.

That was partly down to dealers offloading Treasuries to
hedge a corporate bond deal from Verizon, it nonetheless
continues to suggest persistent uncertainty about appetite for
U.S. government debt.

And as the risk sentiment sours going into the weekend, the
dollar has risen off one-week low against its rivals, slamming
currencies such as the euro and Aussie dollar almost half a
percent lower. An index of emerging market currencies which on
Thursday posted its biggest rise since early-January has fallen
back.

But it's not all bad news. The Nasdaq, despite a recent
recovery, remains well behind the Dow 30, S&P and Russell 2000
indexes which have hit records -- clearly investors, seeing
economic recovery on the horizon, are piling into old economy
stocks such as banks and energy.

Key developments that should provide more direction to markets
on Friday:
-Britain's economy shrank by 2.9% in January from December
-Brent oil prices ease but stay near $70 a barrel
-British luxury group Burberry raises outlook after strong
bounceback in sales;
-Apple's market value could breach $3 trillion if the iPhone
maker successfully makes Apple Car, Citi says,
-Euro area industrial production
-Canada employment report

(Saikat Chatterjee)

*****

EUROPEAN FUTURES TAKE A BREATHER (0633 GMT)

European stock futures are pointing to a session flat or
slightly in the red, as equities seem keen on taking a breather
after a rally which drove the Stoxx 600 index close to
pre-pandemic levels.

Germany’s Dax has been hitting fresh record highs since the
start of the week and many Europe’s benchmark sectoral indexes
are at their highest levels or close to them.

The bigger picture remains favourable to risk sentiment
after the ECB announced an increase of PEPP buying pace to keep
a lid on borrowing costs, while subsiding inflation fears
boosted Wall Street and Asian stocks overnight.

(Stefano Rebaudo)

*****

More News
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.